Cannabinoid receptor 1 is linked to dependence on alcohol and other substances
While researchers know that genetic factors play an important role in the development of alcohol dependence (AD), it is challenging to discover which particular genes may be involved. Prior evidence had established that the endogenous cannabinoid system is implicated in AD, with cannabinoid receptor 1 (CNR1) appearing to be the main candidate. New findings confirm the association between CNR1 and dependence on alcohol and other substances.
Results will be published in the February 2012 issue of Alcoholism: Clinical & Experimental Research and are currently available at Early View.
"Susceptibility to AD is determined by a complex interplay of environmental and genetic factors," said Rogelio González-Sarmiento, professor of medicine at University of Salamanca, Spain and corresponding author for the study. "Allelic variants within specific genes such as single nucleotide polymorphisms may be potential candidates for involvement in the development of AD. Animal models have shown that the CNR1 gene is involved in the reward system. In addition, more than 10 allelic variants have been described within this gene, and several previous studies in humans have shown a relationship of some of these allelic variants with dependence to several substances, including alcohol."
"Many neuronal circuits are potentially involved in AD and the cannabinoid system is very likely one of those circuits," agreed Antonio J. Chamorro, a senior researcher at the University Hospital of Ourense, Spain. "There are other neurotransmitters that may be more important or have been more studied, but the goal of studying the genetics of AD is precisely to understand why some patients develop AD and some do not. That is, in some patients the endogenous cannabinoid system may play a more critical role than in other patients, and this can be due to genetic variants."
González-Sarmiento and his colleagues examined the relationship between three allelic variants of the CNR1 gene (rs6454674, rs1049353, and rs806368) that had previously been associated with addictive disorders. They genotyped these three polymorphisms from the blood cells of 298 male alcoholics: 187 were diagnosed with AD according to the "Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition" (DSM-IV) criteria, and 111 with alcohol abuse. All had been referred to the Alcoholism Unit of the University Hospital of Salamanca, Spain. An additional 155 healthy volunteers served as controls.
"We found that two specific haplotypes a haplotype is a combination of alterations in the normal sequence of a gene that are likely to be inherited together are more frequent in patients with AD than in patients who abuse alcohol," said González-Sarmiento.
"In other words," added Chamorro, "certain patients consuming a large amount of alcohol will be more likely to develop AD according to the possession of specific CNR1 polymorphisms. These results confirm the findings of other researchers that have shown a role for certain haplotypes of the CNR1 gene in [developing] dependence to several substances, including cocaine and alcohol. Therefore, it seems that the possession of certain genetic variants within the CNR1 gene may be a marker of a susceptibility to addictive disorders."
"We still have a road to be traveled in the field of the genetics of AD," noted González-Sarmiento. "It is well known that this disorder has a genetic basis but we have yet to refine this knowledge in order to be able to use it in the clinical care of alcoholic patients."
Provided by Alcoholism: Clinical & Experimental Research
-
The neuropeptide Y system is linked to a more severe form of alcohol dependence
Sep 23, 2008 |
not rated yet |
0
-
Polymorphisms of the interleukin-1 gene complex may influence alcohol dependence
Sep 18, 2009 |
not rated yet |
0
-
Genome-wide study of alcohol dependence points to chromosome 11
Mar 01, 2010 |
not rated yet |
0
-
The aldehyde dehydrogenase-2 polymorphism affects alcohol dependence differently by gender
Aug 15, 2011 |
not rated yet |
0
-
Simplifying measures of genetic risk for alcohol dependence
Apr 05, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Researchers identify new circadian clock component
Northwestern University scientists have shown a gene involved in neurodegenerative disease also plays a critical role in the proper function of the circadian clock.
Genetics
May 16, 2013 |
3 / 5 (1) |
0
|
Returning genetic incidental findings without patient consent violates basic rights, experts say
Informed consent is the backbone of patient care. Genetic testing has long required patient consent and patients have had a "right not to know" the results. However, as 21st century medicine now begins to use the tools of ...
Genetics
May 16, 2013 |
5 / 5 (1) |
3
|
Ethicists provide framework supporting new recommendations on reporting incidental findings in gene sequencing
In a paper published in Science Express, a group of experts led by bioethicists in the Center for Medical Ethics and Health Policy at Baylor College of Medicine provide a framework for the new American College of Medical Geneti ...
Genetics
May 16, 2013 |
not rated yet |
0
Experts urge caution over use of new genetic sequencing techniques
The use of genome-wide analysis (GWA), where the entirety of an individual's DNA is examined to look for the genomic mutations or variants which can cause health problems is a massively useful technology for diagnosing disease. ...
Genetics
May 16, 2013 |
not rated yet |
0
Collecting DNA for human rights: How to help while safeguarding privacy
DNA databases might help identify victims of crime and human trafficking, but how do we safeguard the personal privacy of innocent victims and family members? A new report online May 15 in the Cell Press journal Trends in ...
Genetics
May 15, 2013 |
not rated yet |
0
Researchers identify a potential new risk for sleep apnea: Asthma
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
Study finds that sleep apnea and Alzheimer's are linked
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
Computational tool translates complex data into simplified 2-dimensional images
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
New theory on genesis of osteoarthritis comes with successful therapy in mice
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
Ginger compounds may be effective in treating asthma symptoms
Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...
'Gap' for HIV vaccine efforts after latest setback
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.